Patent Applications published on Jun 11, 2026 - page 3

#601
US20260157856A1
Human necessities

Arcuate Orthopedic Distractor Devices, Systems, and Methods for Treating Mid-Foot Disorders

#602
US20260157857A1
Human necessities

INTERVERTEBRAL DISC IMPLANTS WITH VARYING CUP AND DOME GEOMETRIES

#603
US20260157858A1
Human necessities

INTERVERTEBRAL DISC IMPLANTS HAVING VARYING ENDPLATE GEOMETRIES

#604
US20260157859A1
Human necessities

ADJUSTABLE LORDOSIS EXPANDABLE IMPLANTS AND INSTRUMENTS

#605
US20260157860A1
Human necessities

ONE-STEP INSTRUMENT FOR IMPLANTING STEMLESS PROSTHESES

#606
US20260157861A1
Human necessities

ARTICULATING GRAFT DELIVERY

#607
US20260157862A1
Human necessities

PROCESSED BONE RETAINER

#608
US20260157863A1
Human necessities

COVER FOR A PROSTHETIC HAND AND METHOD FOR PRODUCING SAME

#609
US20260157864A1
Human necessities

APPARATUS AND METHOD FOR ENGAGING PROJECTILES

#610
US20260157865A1
Human necessities

PROSTHETIC THUMB WITH ROTATION AND COMPOUND FLEXION

#611
US20260157866A1
Human necessities

ADJUSTABLE PROSTHETIC

#612
US20260157867A1
Human necessities

STENT WITH IMPROVED ANTI-MIGRATION PROPERTIES

#613
US20260157868A1
Human necessities

STENT HAVING ADJACENT ELEMENTS CONNECTED BY FLEXIBLE WEBS

#614
US20260157869A1
Human necessities

LOADING DEVICE AND METHOD FOR LOADING A PROSTHESIS

#615
US20260157870A1
Human necessities

Stent Delivery Systems

#616
US20260157871A1
Human necessities

SMART KNEE ORTHOSIS WITH INTEGRATED BIOFEEDBACK FOR REAL-TIME PROPRIOCEPTIVE TRAINING

#617
US20260157872A1
Human necessities

ADJUSTABLE DEVICE AND METHOD TO ADJUST ADJUSTABLE DEVICE FOR IMMOBILIZING AND STABILIZING LIMBS

#618
US20260157873A1
Human necessities

BILATERAL ARM STABILIZER SYSTEM

#619
US20260157874A1
Human necessities

ROLL OF ANTI-MOUTH-BREATHING TAPE AND METHOD OF RESTRICTING BREATHING THROUGH A MOUTH OF A USER USING THE ROLL OF ANTI-MOUTH-BREATHING TAPE

#620
US20260157875A1
Human necessities

MULTI-MODE PORTABLE EVAPORATIVE COOLER

#621
US20260157876A1
Human necessities

INFRARED THERAPY CHAMBER

#622
US20260157877A1
Human necessities

EXTERNAL THERMAL GRILL PELTIER DEVICE AND METHOD TO STIMULATE NERVES AND MUSCLES

#623
US20260157878A1
Human necessities

SINGLE-USE MEDICAL WARMING BLANKET ASSEMBLY

#624
US20260157879A1
Human necessities

SQUEEZABLE CONTAINERS WITH INTEGRATED VALVE FOR MULTIDOSE DISPENSING

#625
US20260157880A1
Human necessities

DEVICE FOR AND METHOD OF NUMBING THE EYE OF A LIVING BEING

#626
US20260157881A1
Human necessities

DEVICES AND SYSTEMS FOR CUTTING, LOADING, AND DELIVERING BIOLOGIC INTRAOCULAR IMPLANTS FOR INCREASED AQUEOUS OUTFLOW AND LOWERING OF INTRAOCULAR PRESSURE

#627
US20260157882A1
Human necessities

TILT-RETRACTION EYE DROP DISPENSER, SYSTEM AND METHOD

#628
US20260157883A1
Human necessities

Control of Intraocular Pressure During Phacoemulsification

#629
US20260157884A1
Human necessities

SLEEVE, USE OF AN ULTRASHORT PULSE LAYER, METHOD FOR PROCESSING A SLEEVE BLANK AND METHOD FOR MANUFACTURING A SLEEVE

#630
US20260157885A1
Human necessities

ARTIFICIAL INTELLIGENCE PLATFORM FOR SURGICAL VIDEO CLASSIFICATION

#631
US20260157886A1
Human necessities

MULTIFUNCTION OPHTHALMIC BLADE AND BLADE GUARD

#632
US20260157887A1
Human necessities

SYSTEM FOR SHAPING AND IMPLANTING BIOLOGIC INTRAOCULAR STENT FOR INCREASED AQUEOUS OUTFLOW AND LOWERING OF INTRAOCULAR PRESSURE

#633
US20260157888A1
Human necessities

METHODS FOR USING VIOLET LASER ENERGY TO ADJUST THE REFRACTIVE PROPERTIES OF IMPLANTED INTRAOCULAR LENSES

#634
US20260157889A1
Human necessities

Sport Safety Glasses

#635
US20260157890A1
Human necessities

PROCESS FOR MAKING ANTIINFLAMMATORY, ANTIBACTERIAL, ANTIFUNGAL AND VIRICIDAL MATERIALS

#636
US20260157891A1
Human necessities

ARM SLEEVE THAT PROVIDES ASSISTANCE DURING AN ARM MOTION

#637
US20260157892A1
Human necessities

LEG GASKETING SYSTEM FOR ABSORBENT ARTICLES

#638
US20260157893A1
Human necessities

MULTILAYERED TEXTILE MATERIAL FOR CONTAINING LIQUIDS AND ASSOCIATED SYSTEMS AND METHODS

#639
US20260157894A1
Human necessities

VISUALLY COORDINATED DISPOSABLE ABSORBENT ARTICLES

#640
US20260157895A1
Human necessities

HEATED GURNEY FOR MAINTAING PATIENT BODY TEMPERATURE

#641
US20260157896A1
Human necessities

VEHICLE ACCESS SYSTEM WITH ENHANCED INSTALLATION AND USABILITY FEATURES AND SECUREMENT SOLUTIONS

#642
US20260157897A1
Human necessities

A WHEEL ASSEMBLY FOR A MANUAL WHEELCHAIR

#643
US20260157898A1
Human necessities

WHEELCHAIR-INTEGRATED EXOSKELETON ASSEMBLY

#644
US20260157899A1
Human necessities

BED FRAME

#645
US20260157900A1
Human necessities

METHOD OF FORMING A MATTRESS BLADDER FORMING A PLANAR SUPPORT SURFACE

#646
US20260157901A1
Human necessities

OVERHEAD SUPPORT ASSEMBLIES INCLUDING A BOOM ARM AND A RAIL FOR A PERSON LIFT SYSTEM

#647
US20260157902A1
Human necessities

MOBILE PATIENT CONTAINMENT CHAMBER SYSTEM AND METHOD

#648
US20260157903A1
Human necessities

AUTOMATIC PRESSURE CONTROL SYSTEM AND METHOD OF HYPERBARIC OXYGEN CHAMBER FOR DETECTING PRESSURE EQUALIZATION BETWEEN EXTERNAL EAR AND MIDDLE EAR

#649
US20260157904A1
Human necessities

SUPPORT FOR SECURING A ROBOTIC SYSTEM TO A PATIENT TABLE

#650
US20260157905A1
Human necessities

SYSTEMS, DEVICES, AND METHODS FOR CONTROLLING PATIENT SUPPORT DEVICES

#651
US20260157906A1
Human necessities

MEDICAL JACK STAND

#652
US20260157907A1
Human necessities

CERVICAL SPINE POSITIONING APPARATUS AND METHOD

#653
US20260157908A1
Human necessities

POSITIONING DEVICE FOR HOLDING AND PROTECTING A PATIENT'S ARM DURING A MEDICAL PROCEDURE

#654
US20260157909A1
Human necessities

SURGICAL TABLE CLADDING PROTECTION DEVICE AND METHODS

#655
US20260157910A1
Human necessities

ANTERIOR BOOT FOR HIP DISTRACTION

#656
US20260157911A1
Human necessities

CHIROPRACTIC ADJUSTING INSTRUMENT SYSTEM AND METHOD

#657
US20260157912A1
Human necessities

Hip and Leg Stretching Apparatus

#658
US20260157913A1
Human necessities

Torso Interface for a Trunk Supporting Exoskeleton

#659
US20260157914A1
Human necessities

SPINAL ALIGNMENT APPARATUS

#660
US20260157915A1
Human necessities

KNEE JOINT AUXILIARY DEVICE AND MECHANISM HAVING POWER SOURCE ASSEMBLY

#661
US20260157916A1
Human necessities

ENABLING THE VISUALLY IMPAIRED WITH AR USING FORCE FEEDBACK

#662
US20260157917A1
Human necessities

CONTROLLERS DESIGNED FOR MULTI-COMPONENT USE AND APPROACHES TO USING THE SAME TO INFLATE MULTIPLE PRESSURE-MITIGATION APPARATUSES

#663
US20260157918A1
Human necessities

HANDHELD EYELID MASSAGER

#664
US20260157919A1
Human necessities

MASSAGE BALL WITH IMPROVED HEAT TRANSFER PERFORMANCE

#665
US20260157920A1
Human necessities

MALE MASTURBATOR WITH TELESCOPING AND ROTATING MECHANISM

#666
US20260157921A1
Human necessities

Self-Lubricating Sexual Stimulation Toy

#667
US20260157922A1
Human necessities

DEVICE, METHOD, AND SYSTEM FOR COLORECTAL PELVIC FLOOR REHABILITATION

#668
US20260157923A1
Human necessities

VARIABLE AMPLITUDE ADJUSTING MECHANISM AND FASCIA GUN WITH THE SAME

#669
US20260157924A1
Human necessities

SYSTEM AND METHODS FOR CONTROLLING A SMART EXERCISE RECOVERY DEVICE AND MITIGATION OF DAMAGE FROM VIBRATIONS

#670
US20260157925A1
Human necessities

MASSAGE CORE MECHANISM

#671
US20260157926A1
Human necessities

PHYSIOLOGICAL IMPLEMENTS UTILIZING MAGNETS AND TERAHERTZ MATERIAL

#672
US20260157927A1
Human necessities

METHOD FOR IMPROVING ATTENTION FUNCTION OF A SUBJECT, METHOD FOR IMPROVING FLUENCY OF A SUBJECT, AND METHOD FOR IMPROVING CONGNITIVE FUNCTION OF A SUBJECT

#673
US20260157928A1
Human necessities

DRIVING DEVICE FOR MASSAGER AND MASSAGER

#674
US20260157929A1
Human necessities

CPR DEVICE WITH MANUAL ACTIVATION OF ACTIVE DECOMPRESSION AND FORCE MEASUREMENT OF ACTIVE DECOMPRESSION

#675
US20260157930A1
Human necessities

SPA CHAIR WITH A FACIAL DOME AND RELATED METHODS

#676
US20260157931A1
Human necessities

Height adjustable moving module and acupressure bed having the same

#677
US20260157932A1
Human necessities

DEVICES AND METHODS FOR DELIVERY OF MULTI-COMPONENT FLUIDS

#678
US20260157933A1
Human necessities

MEDICATION SUPPORT APPARATUS

#679
US20260157934A1
Human necessities

Pill Storage and Dispensing System

#680
US20260157935A1
Human necessities

ELECTRONICALLY ENABLED PILL ORGANIZER

#681
US20260157936A1
Human necessities

GUIDED COLORED NASOGASTRIC TUBE (GCNGT)

#682
US20260157937A1
Human necessities

NATURAL-LOOKING DENTAL PROSTHESIS

#683
US20260157938A1
Human necessities

Curable Composition for Use in a Process of Treating a Dental Situation in the Mouth of a Patient

#684
US20260157939A1
Human necessities

BIOACTIVE GLASS COMPOSITIONS AND METHODS FOR PERIODONTAL THERAPIES AND TOOTH STABILIZATION

#685
US20260157940A1
Human necessities

HYBRID RESIN BLANK FOR DENTAL MILLING, AND METHOD FOR FABRICATING CROWN

#686
US20260157941A1
Human necessities

DENTAL CEMENT AND DENTAL CEMENT PREPARATION KIT

#687
US20260157942A1
Human necessities

METHOD FOR ENCAPSULATING ACTIVE INGREDIENT AND IMPROVING STABILITY USING MICELLE

#688
US20260157943A1
Human necessities

COMPOSITION FOR FOUNDATION IN SPRAY FORM

#689
US20260157944A1
Human necessities

LIPID-BASED MICROCAPSULES

#690
US20260157945A1
Human necessities

COMPOSITIONS AND METHODS FOR PROMOTING MINERALIZATION

#691
US20260157946A1
Human necessities

BROAD-SPECTRUM, MINERAL, PHOTOPROTECTIVE COMPOSITIONS

#692
US20260157947A1
Human necessities

HYDRATABLE CONCENTRATED SURFACTANT COMPOSITIONS

#693
US20260157948A1
Human necessities

PROCESS FOR DYEING AND/OR LIGHTENING KERATIN FIBERS

#694
US20260157949A1
Human necessities

GEL COMPOSITION, THE PREPARATION METHOD AND THE USE OF THE SAME

#695
US20260157950A1
Human necessities

Compounds and Cosmetic, Dermocosmetic, Cosmeceutical or Pharmaceutical Compositions for Relaxing Muscles, Including the Skeletal Muscles of the Face, for Anti-Aging Cosmetic Action, for Reducing and/or Smoothing Expression Lines and Wrinkles and/or for Antiperspirant Action, Uses and Methods

#696
US20260157951A1
Human necessities

METHODS AND COMPOSITIONS FOR HAIR FOLLICLE REGENERATION AND HAIR GROWTH

#697
US20260157952A1
Human necessities

COSMETIC COMPOSITION AND METHODS OF USE THEREOF

#698
US20260157953A1
Human necessities

HAIR TREATMENT COMPOSITIONS AND METHODS

#699
US20260157954A1
Human necessities

ANHYDROUS COSMETIC COMPOSITION

#700
US20260157955A1
Human necessities

DEDIFFERENTIATED PLANT CELLS OF THE GENUS PAEONIA, EXTRACTS THEREOF AND COSMETIC USES THEREOF

#701
US20260157956A1
Human necessities

METHOD FOR ISOLATING PLANT-DERIVED EXOSOME, EXOSOME ISOLATED THEREBY, AND COSMETIC USE THEREOF

#702
US20260157957A1
Human necessities

TOPICAL USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

#703
US20260157958A1
Human necessities

METHOD AND APPARATUS FOR DELIVERING AN API-CONTAINING LIQUID TO AN EDIBLE SUBSTRATE

#704
US20260157959A1
Human necessities

INHALABLE RECOMBINANT PROTEIN POWDER FORMULATION FOR TREATING GENETIC AND AUTOIMMUNE DISORDERS

#705
US20260157960A1
Human necessities

RHEOLOGICALLY SYNOVIAL FLUID-LIKE HYDROGEL FORMULATIONS FOR USING IN INTRA-ARTICULAR APPLICATIONS

#706
US20260157961A1
Human necessities

APPLICATION OF NANOGEL IN USE OR PREPARATION OF ANTI-TUMOR DRUG

#707
US20260157962A1
Human necessities

Compositions of Stannic Protoporfin for Long Term Stability and Container Closure Systems for Storing Stannic Protoporfin

#708
US20260157963A1
Human necessities

MIXTURE, AQUEOUS SOLUTION CONTAINING THE MIXTURE, AND USES OF THE AQUEOUS SOLUTION

#709
US20260157964A1
Human necessities

LIPOPHILIC STATIN COMPOSITION WITH IMPROVED SOLUBILITY AND PERMEABILITY AND USES THEREOF

#710
US20260157965A1
Human necessities

GOLD NANOPARTICLE COMPOSITION AND USES THEREOF

#711
US20260157966A1
Human necessities

FUSOGENIC LIPOSOMES FOR INTRACELLULAR DELIVERY OF PHOSPHOCREATINE

#712
US20260157967A1
Human necessities

METHOD FOR PREPARING MEDICINES, HAVING REDUCED PRODUCTION TIME AND IMPROVED STABILITY

#713
US20260157968A1
Human necessities

Method and Composition for an Improved Bioavailability Delivery System

#714
US20260157969A1
Human necessities

LYOPHILIZED COMPOSITIONS AND USES OF SAME

#715
US20260157970A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#716
US20260157971A1
Human necessities

FORMULATIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS

#717
US20260157972A1
Human necessities

IMAGING-GUIDED BIORESORBABLE ACOUSTIC HYDROGEL MICROROBOTS

#718
US20260157973A1
Human necessities

CATIONIC POLYESTER COMPOSITIONS WITH DEFINED TERMINAL-GROUP RATIO AND USE THEREOF

#719
US20260157974A1
Human necessities

DRUG-RELEASING NANOPARTICLE-ENHANCED HYDROGEL, PREPARATION METHOD THEREFOR, AND USE THEREOF

#720
US20260157975A1
Human necessities

SILOXANE NANOCOMPOSITE MATERIAL AND ITS PREPARATION METHOD AND APPLICATION

#721
US20260157976A1
Human necessities

DICLOFENAC-CONTAINING TTS COMPRISING DIMETHYLPROPYLENEUREA

#722
US20260157977A1
Human necessities

OCCLUSIVE PLASTER WITH FLEXIBLE BACKING

#723
US20260157978A1
Human necessities

PROTRUSION PATCH AND METHOD FOR MANUFACTURING SAME

#724
US20260157979A1
Human necessities

PLANT BASED SUPPLEMENT COMPOSITIONS

#725
US20260157980A1
Human necessities

METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 IN COMBINATION WITH IMMUNE CHECKPOINT MODULATORS

#726
US20260157981A1
Human necessities

Compositions Comprising Fingolimod or a Salt Thereof

#727
US20260157982A1
Human necessities

EPINEPHRINE LIQUID FORMULATIONS

#728
US20260157983A1
Human necessities

DOFETILIDE FORMULATIONS

#729
US20260157984A1
Human necessities

CERAMIDE COMPOSITION

#730
US20260157985A1
Human necessities

METHOD TO TREAT SYMPTOMS ASSOCIATED WITH ACNE, ECZEMA, PSORIASIS, AND RELATED DERMATOLOGICAL CONDITIONS WITH COMPOSITION COMPRISING A PROANTHOCYANIDIN, SPHINGOLIPID, AND SULPHUR COMPOUNDS

#731
US20260157986A1
Human necessities

METHODS OF TREATMENT OF PRIMARY BILIARY CHOLANGITIS

#732
US20260157987A1
Human necessities

VIRAL INACTIVATION SPRAY AND GARGLING FORMULATION

#733
US20260157988A1
Human necessities

Method Of Treatment Of Obesity

#734
US20260157989A1
Human necessities

DIETARY BUTYRATE

#735
US20260157990A1
Human necessities

Drug For Treating And Preventing Dementia

#736
US20260157991A1
Human necessities

Teriflunomide Topical Pharmaceutical Compositions

#737
US20260157992A1
Human necessities

AGENT FOR PROTECTION OF BLOOD BRAIN SPINAL CORD BARRIER

#738
US20260157993A1
Human necessities

USE OF 2-METHYLOXOLANE FOR FEEDING OVIPAROUS ANIMALS

#739
US20260157994A1
Human necessities

ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS

#740
US20260157995A1
Human necessities

ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

#741
US20260157996A1
Human necessities

COMPOSITION FOR MODULATING THE HIPPO-YAP PATHWAY AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER

#742
US20260157997A1
Human necessities

COMPOSITIONS FOR HYDRATING SUPPLEMENTS AND METHODS OF USE

#743
US20260157998A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES

#744
US20260157999A1
Human necessities

DEUTERATED FORMS OF ALKALOID COMPOUNDS AND THERAPEUTIC USES THEREOF

#745
US20260158000A1
Human necessities

COMBINED MAPK AND NAMPT INHIBITION FOR TREATMENT OF NEURON DEGENERATION

#746
US20260158001A1
Human necessities

METHOD FOR PREVENTING AND/OR TREATING CHRONIC TRAUMATIC ENCEPHALOPATHY-I

#747
US20260158002A1
Human necessities

APPLICATION OF COMPOSITION CONTAINING EDARAVONE AND DEXBORNEOL IN IMPROVING OR TREATING COGNITIVE IMPAIRMENT

#748
US20260158003A1
Human necessities

METHODS TO TARGET THE SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR PATHWAY FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS

#749
US20260158004A1
Human necessities

Local and Regional Anesthesia and Analgesia

#750
US20260158005A1
Human necessities

A SALT-BASED ANTIFUNGAL POWDER PLATFORM FORMULATION FOR AEROSOLIZATION

#751
US20260158006A1
Human necessities

FORMULATION OF A RILUZOLE SOLUTION WITH BETA-CYCLODEXTRINS

#752
US20260158007A1
Human necessities

INHIBITION OF BACH1 FOR PULMONARY HYPERTENSION THERAPY

#753
US20260158008A1
Human necessities

POLYMORPHS OF THE MESYLATE SALT OF LINAPRAZAN GLURATE

#754
US20260158009A1
Human necessities

ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF

#755
US20260158010A1
Human necessities

PHARMACEUTICAL FORMULATIONS CONTAINING RELACORILANT, A HETEROARYL-KETONE FUSED AZADECALIN COMPOUND

#756
US20260158011A1
Human necessities

COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF

#757
US20260158012A1
Human necessities

SORAFENIB OR DONAFENIB ORAL PREPARATION WITH LOW DOSE AND HIGH DRUG EXPOSURE, AND APPLICATION THEREOF

#758
US20260158013A1
Human necessities

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF OBESITY AND OBESITY-INDUCED DISEASE

#759
US20260158014A1
Human necessities

METHODS OF ADMINISTERING VOXELOTOR

#760
US20260158015A1
Human necessities

PHARMACEUTICAL COMPOSITION, ITS USE AS A DRUG AND NEW COMPOUNDS, ESPECIALLY FOR TREATING SARS-COV-2 INFECTION

#761
US20260158016A1
Human necessities

HALOPERIDOL DERIVATIVES, PHARMACEUTICAL COMPOSITION COMPRISING SAID DERIVATIVES, AND THERAPEUTIC USES THEREOF

#762
US20260158017A1
Human necessities

KIF18A INHIBITOR

#763
US20260158018A1
Human necessities

PERFUSATE CONTAINING NICOTINAMIDE FOR INTRAOCULAR SURGERY, METHOD OF PREPARATION AND USE THEREOF

#764
US20260158019A1
Human necessities

COMPOSITIONS FOR TREATING AND/OR PREVENTING SUBSTANCE USE DISORDERS IN SUBJECTS IN NEED THEREOF

#765
US20260158020A1
Human necessities

COMPOSITIONS AND USES THEREOF

#766
US20260158021A1
Human necessities

PREVENTION AND TREATMENT OF ORGAN FIBROSIS

#767
US20260158022A1
Human necessities

ORAL FORMULATION OF A THERAPEUTIC COMPOUND

#768
US20260158023A1
Human necessities

APOMORPHINE FOR TREATING OR IMPROVING POST-TRAUMATIC STRESS DISORDER

#769
US20260158024A1
Human necessities

KRAS INHIBITORS

#770
US20260158025A1
Human necessities

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

#771
US20260158026A1
Human necessities

METHODS OF TREATING CANCER AND COMPOSITIONS FOR THE SAME

#772
US20260158027A1
Human necessities

SMALL MOLECULE DIRECT INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION

#773
US20260158028A1
Human necessities

USE OF QUINOLINONE DERIVATIVE IN TREATMENT OF IMMUNE THROMBOCYTOPENIA

#774
US20260158029A1
Human necessities

FIVE-MEMBERED RING-FUSED SIX-MEMBERED RING COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

#775
US20260158030A1
Human necessities

VASOCONSTRICTION COMPOSITIONS AND METHODS OF USE

#776
US20260158031A1
Human necessities

AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USE THEREOF

#777
US20260158032A1
Human necessities

PARP AND ADAR1 INHIBITION FOR CANCER TREATMENT

#778
US20260158033A1
Human necessities

VECABRUTINIB FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE

#779
US20260158034A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#780
US20260158035A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#781
US20260158036A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#782
US20260158037A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#783
US20260158038A1
Human necessities

TREATMENT USE OF PYRROLOPYRIMIDINE COMPOUND, AND SOLID PHARMACEUTICAL COMPOSITION OF PYRROLOPYRIMIDINE COMPOUND

#784
US20260158039A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INVOLUNTARY MOVEMENTS RELATED TO DOPAMINERGIC DYSFUNCTION

#785
US20260158040A1
Human necessities

ORALLY ADMINISTERED COMBINATIONS OF BETA LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

#786
US20260158041A1
Human necessities

COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING ADENOID CYSTIC CARCINOMA

#787
US20260158042A1
Human necessities

Method and Composition for an Improved Bioavailability Delivery System

#788
US20260158043A1
Human necessities

STEROID AS A MODULATOR OF GABAA RECEPTOR

#789
US20260158044A1
Human necessities

COMPOSITION FOR THE TREATMENT OF COVID-19

#790
US20260158045A1
Human necessities

METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS

#791
US20260158046A1
Human necessities

TREATMENT OF NEURODEGENERATIVE DISORDERS WITH DOXYCYCLINE ALONE OR IN COMBINATION WITH LEVODOPA

#792
US20260158047A1
Human necessities

A VVN001-CONTAINING OPHTHALMIC COMPOSITION

#793
US20260158048A1
Human necessities

METHODS OF TREATMENT

#794
US20260158049A1
Human necessities

METHODS OF PREVENTING CONGENITAL HEART DEFECTS INDUCED BY MATERNAL DIABETES USING ACTIVATORS OF MITOCHONDRIAL FUSION

#795
US20260158050A1
Human necessities

USE OF EIDD-1931 OR DERIVATIVE THEREOF IN TREATMENT OF ENTEROVIRUS INFECTION

#796
US20260158051A1
Human necessities

Compositions and Methods for Treating and Preventing Prekallikrein-Associated Conditions

#797
US20260158052A1
Human necessities

THERAPEUTIC AGENT, PROGRESSION INHIBITOR, AND PREVENTIVE AGENT FOR NEURODEGENERATIVE DISORDERS CHARACTERIZED BY AGGREGATION OF TDP43, TDP35, OR TDP25

#798
US20260158053A1
Human necessities

DNA COMPOSITIONS AND RELATED METHODS

#799
US20260158054A1
Human necessities

METHODS FOR TREATING MUSCULAR DYSTROPHY

#800
US20260158055A1
Human necessities

METHOD FOR TREATMENT OF CORONAVIRUS INFECTION

#801
US20260158056A1
Human necessities

USE OF LOW MOLECULAR WEIGHT HYALURONIC ACID FOR THE TREATMENT OF LUNG MUCOSAL INFLAMMATION

#802
US20260158057A1
Human necessities

COMPOSITION CONTAINING HYALURONIC ACIDS OR SALTS THEREOF FOR IMPROVING IMMUNITY OF ORGANISM AND PROMOTING HEALTH OF GASTROINTESTINAL TRACT, AND USE THEREOF

#803
US20260158058A1
Human necessities

METHOD AND PRODUCT FOR TREATING ACNE, AND METHOD FOR PREPARING THE PRODUCT

#804
US20260158059A1
Human necessities

READY-TO-USE SODIUM BICARBONATE FORMULATIONS AND PRODUCTS

#805
US20260158060A1
Human necessities

IRON NANOCLUSTERS, METHODS FOR OBTAINING SAME AND USES THEREOF FOR COMBATTING IRON DEFICIENCIES

#806
US20260158061A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING, AS ACTIVE INGREDIENT, MONOCYTES OR MACROPHAGES IN WHICH EXPRESSION OR ACTIVITY OF CD244 IS INHIBITED

#807
US20260158062A1
Human necessities

CRYOPRECIPITATE COMPOSITIONS AND METHODS OF PREPARATION THEREOF

#808
US20260158063A1
Human necessities

COMPOSITIONS AND METHODS FOR EMR2 MODIFICATION

#809
US20260158064A1
Human necessities

SINGLE DOMAIN ANTIBODY TARGETING HUMAN ROR1

#810
US20260158065A1
Human necessities

TARGETED DISRUPTION OF THE MHC CELL RECEPTOR

#811
US20260158066A1
Human necessities

Cell Therapeutics With Improved Persistence In Vivo And Antitumor Effect, And A Method For Producing Thereof

#812
US20260158067A1
Human necessities

VECTOR FOR EXPRESSION OF CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

#813
US20260158068A1
Human necessities

HUMAN IFN-ALPHA2 AND PD-L1 OVEREXPRESSING T CELLS FOR IMMUNE MODULATION OF AUTOIMMUNE AND ALLOIMMUNE DISORDERS

#814
US20260158069A1
Human necessities

CHIMERIC TIM RECEPTORS AND USES THEREOF

#815
US20260158070A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS ASSOCIATED WITH SURFACE K-RAS

#816
US20260158071A1
Human necessities

EXTRACELLULAR VESICLES FROM CHEMICAL HYPOXIA-PRECONDITIONED MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF VIRUS-INDUCED ACUTE LUNG INJURY

#817
US20260158072A1
Human necessities

COMPOSITION AND METHOD FOR PREVENTING OR TREATING OPTIC NEUROPATHY

#818
US20260158073A1
Human necessities

COMPOSITIONS AND METHODS FOR ASSESSING, TREATING, OR REDUCING AGING-RELATED FUNCTIONAL DECLINE

#819
US20260158074A1
Human necessities

A Cell Surface Marker Signature for Arrhythmogenic Pluripotent Stem Cell-Derived Cardiomyocytes

#820
US20260158075A1
Human necessities

COMPOSITIONS AND METHODS OF TREATING LIVER DISEASE

#821
US20260158076A1
Human necessities

HYDROGEL AND USES THEREOF

#822
US20260158077A1
Human necessities

Immature Pluripotent Fat Adult Stem Cell to Treat Multiple Human Diseases

#823
US20260158078A1
Human necessities

Methods and Compositions for Managing and/or Alleviating Symptoms of Muscular Dystrophies and Other Genetic Muscular Disorders

#824
US20260158079A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA

#825
US20260158080A1
Human necessities

HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#826
US20260158081A1
Human necessities

BACTERIAL STRAIN AND MEDICAL USES THEREOF

#827
US20260158082A1
Human necessities

ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT

#828
US20260158083A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING INFECTIOUS, AUTOIMMUNE, AND ALLERGIC DISEASE

#829
US20260158084A1
Human necessities

BACILLUS STRAINS FOR IMPROVING ANIMAL PERFORMANCE PARAMETERS

#830
US20260158085A1
Human necessities

ORAL HYGIENE FORMULATION

#831
US20260158086A1
Human necessities

WHOLE CELL, HEAT-KILLED POSTBIOTIC BLEND

#832
US20260158087A1
Human necessities

HERPESVIRAL COMBINATION THERAPY FOR TARGETING CANCER CELLS AND CANCER ASSOCIATED STROMAL CELLS

#833
US20260158088A1
Human necessities

COMPOSITION FOR CURING HANGOVER OR IMPROVING LIVER FUNCTION, COMPRISING PINE HEARTWOOD EXTRACT AS ACTIVE INGREDIENT

#834
US20260158089A1
Human necessities

COMPOSITION COMPRISING MANGO EXTRACT FOR PREVENTION OF HAIR LOSS

#835
US20260158090A1
Human necessities

PRODUCTS TO TREAT AND/OR PREVENT MENSTRUAL SYMPTOMS

#836
US20260158091A1
Human necessities

SYSTEMS AND TECHNIQUES FOR EXTRACTING HEMP SEED OIL

#837
US20260158092A1
Human necessities

COMPOSITION COMPRISING AT LEAST ONE CANNABIS EXTRACT FOR USE IN THE TREATMENT OF AN INFLAMMATORY BOWEL DISEASE

#838
US20260158093A1
Human necessities

BIOAVAILABLE COMPOSITIONS COMPRISING CANNABINOIDS AND CYCLODEXTRINS

#839
US20260158094A1
Human necessities

COMPOSITION FOR PREVENTING, IMPROVING OR TREATING SKELETAL MUSCLE ATROPHY OR SARCOPENIA COMPRISING EXTRACT OR ISOLATED COMPOUND FROM STELLARIA DICHOTOMA AS ACTIVE INGREDIENT

#840
US20260158095A1
Human necessities

PLANT EXTRACT AND USE THEREOF IN TOPICAL COMPOSITIONS

#841
US20260158096A1
Human necessities

Methods and Formulations for Immuno-Rejuvenation to Prevent or Mitigate Inflammaging Through the Epigenetic Impact of a Polyphenol-Rich Agent Derived from Uniquely Applied Tartary Buckwheat

#842
US20260158097A1
Human necessities

ANTI-BACTERIAL COMPOSITION COMPRISING EXTRACT OF COFFEE COMPOSITION AND ANTIBIOTIC, AND METHOD FOR TREATING BACTERIAL INFECTION BY USING THE SAME

#843
US20260158098A1
Human necessities

ETIOLATED GREEN TEA POLYSACCHARIDE AND ITS EXTRACTION METHOD AND APPLICATION

#844
US20260158099A1
Human necessities

METHOD FOR TREATING STOMACH DISORDERS

#845
US20260158100A1
Human necessities

ENZYME FOOD FOR MAINTAINING BODY BALANCE AND PREVENTING METABOLIC SYNDROME THROUGH ENZYMES

#846
US20260158101A1
Human necessities

Methods for Treating HCV

#847
US20260158102A1
Human necessities

CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING NEUROPATHIC PAIN AND/OR INFLAMMATORY PAIN

#848
US20260158103A1
Human necessities

USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS

#849
US20260158104A1
Human necessities

Conformationally Specific Viral Immunogens

#850
US20260158105A1
Human necessities

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

#851
US20260158106A1
Human necessities

PEPTIDES AND METHODS OF USE THEREOF IN TREATING UVEITIS

#852
US20260158107A1
Human necessities

SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE

#853
US20260158108A1
Human necessities

MODIFIED MRNA THERAPEUTICS

#854
US20260158109A1
Human necessities

CD200AR LIGANDS FOR CANCER IMMUNOTHERAPY

#855
US20260158110A1
Human necessities

FIBROBLAST GROWTH FACTOR-21-FC FUSION PROTEINS

#856
US20260158111A1
Human necessities

USE OF TGF IN THE PREVENTION VIRUS INFECTION OF THE RESPIRATORY TRACT

#857
US20260158112A1
Human necessities

PROTEIN COMPLEX BY USE OF A SPECIFIC SITE OF AN IMMUNOGLOBULIN FRAGMENT FOR LINKAGE

#858
US20260158113A1
Human necessities

GLP-1 RECEPTOR AGONIST

#859
US20260158114A1
Human necessities

Method for Treating Skeletal Articulations and Composition and Uses Thereof

#860
US20260158115A1
Human necessities

TYPE I COLLAGEN PEPTIDE FOR THERAPEUTIC USE

#861
US20260158116A1
Human necessities

RECOMBINANT COLLAGEN IONIC LIQUID COMPOSITION, PRODUCTION METHOD THEREOF, AND USE THEREOF

#862
US20260158117A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS USING MESENCHYMAL STROMAL CELL-SECRETED LACTOFERRIN FOR TREATING VIRUS-INDUCED ACUTE LUNG INJURY

#863
US20260158118A1
Human necessities

VIRAL VECTORS COMPRISING RDH12 CODING REGIONS AND METHODS OF TREATING RETINAL DYSTROPHIES

#864
US20260158119A1
Human necessities

INTESTINAL ALKALINE PHOSPHATASES AND METHODS OF USE IN INHIBITING LIVER FIBROSIS

#865
US20260158120A1
Human necessities

FUNGAL-DERIVED ENZYME COMPOSITION AND METHOD FOR TREATING EXOCRINE PANCREATIC INSUFFICIENCY

#866
US20260158121A1
Human necessities

TREATMENT OF A HEADACHE DISORDER WITH A BOTULINUM NEUROTOXIN A

#867
US20260158122A1
Human necessities

DOSING AND ADMINISTRATION OF RECOMBINANT L-ASPARAGINASE

#868
US20260158123A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING FRUCTOSE INTOLERANCE AND FRUCTOSE MALABSORPTION

#869
US20260158124A1
Human necessities

UNIVERSAL DONOR CELLS AND RELATED METHODS

#870
US20260158125A1
Human necessities

PEPTIDE VACCINE

#871
US20260158126A1
Human necessities

RUMINAL AND METHANOGEN VACCINES AND USES THEREOF

#872
US20260158127A1
Human necessities

ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED

#873
US20260158128A1
Human necessities

IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA

#874
US20260158129A1
Human necessities

NUCLEIC ACID INFLUENZA VACCINES AND RESPIRATORY VIRUS COMBINATION VACCINES

#875
US20260158130A1
Human necessities

LOW-SUGAR INFLUENZA VACCINE AND METHODS THEREOF

#876
US20260158131A1
Human necessities

ROTAVIRUS B VIRUS-LIKE-PARTICLE COMPOSTIONS AND ANTIBODY ASSAYS

#877
US20260158132A1
Human necessities

SERUM FREE INTRACELLULAR PATHOGEN VACCINE

#878
US20260158133A1
Human necessities

STABILIZATION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) ENVELOPES

#879
US20260158134A1
Human necessities

COMPOSITIONS SUITABLE FOR USE IN A METHOD FOR ELICITING CROSS-PROTECTIVE IMMUNITY AGAINST CORONAVIRUSES

#880
US20260158135A1
Human necessities

VARIANT STRAIN-BASED CORONAVIRUS VACCINES AND USES THEREOF

#881
US20260158136A1
Human necessities

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

#882
US20260158137A1
Human necessities

METHODS OF TREATING MULTIPLE MYELOMA WITH BCMA INHIBITORS IN COMBINATION WITH LAG3 INHIBITORS

#883
US20260158138A1
Human necessities

METHODS OF TREATING TUMORS

#884
US20260158139A1
Human necessities

CARD9 VARIANT POLYPEPTIDE AND ANTIBODIES DIRECTED THERETO

#885
US20260158140A1
Human necessities

METHODS AND MATERIALS FOR IMPROVING T CELL THERAPIES

#886
US20260158141A1
Human necessities

USE OF THP IN PREPARATION OF MEDICAMENT FOR ENHANCING ANTITUMOR EFFICACY OF Vy9V§2 T CELLS

#887
US20260158142A1
Human necessities

CELL THERAPY FOR ALZHEIMER'S DISEASE

#888
US20260158143A1
Human necessities

ANTI-MESOTHELIN ANTIBODY REAGENTS

#889
US20260158144A1
Human necessities

PHOTODYNAMIC THERAPY ILLUMINATOR DEVICES AND METHODS

#890
US20260158145A1
Human necessities

QUINOLINE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION

#891
US20260158146A1
Human necessities

EXTERNAL PREPARATION COMPRISING NON-LAMELLAR LIQUID CRYSTAL-FORMING LIPID

#892
US20260158147A1
Human necessities

METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS

#893
US20260158148A1
Human necessities

PRODRUG INTENDED FOR THE TREATMENT OF BACTERIAL INFECTIONS RESISTANT TO ANTIBIOTICS OF THE BETA-LACTAM FAMILY

#894
US20260158149A1
Human necessities

GLYCOSYLATED PRODRUGS

#895
US20260158150A1
Human necessities

COMPOUNDS, COMPOSITIONS, METHODS, AND USES FOR TREATING INSULIN RESISTANCE, TYPE 2 DIABETES AND METABOLIC SYNDROME

#896
US20260158151A1
Human necessities

PEG-PPS NANOCARRIER DELIVERY OF THE RAS/RAP1 SPECIFIC ENDOPEPTIDASE

#897
US20260158152A1
Human necessities

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

#898
US20260158153A1
Human necessities

BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE

#899
US20260158154A1
Human necessities

Methods of Treating Cancer Using Anti-HER2 Antibody-Drug Conjugates

#900
US20260158155A1
Human necessities

ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATES AND ANTI-VEGFR-2 ANTIBODIES